Literature DB >> 4299222

Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.

A L Graber, D Porte, R H Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4299222     DOI： 10.1111/j.1749-6632.1968.tb19055.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Diazoxide in the management of patients with insulinoma.

Authors:  P N Goode; J R Farndon; J Anderson; I D Johnston; J A Morte
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Treatment of malignant insulinoma with Streptozotocin.

Authors:  C K Smith; R W Stoll; J Vance; H Ricketts; R H Williams
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

3.  Haemodynamic and metabolic effects of diazoxide during rest and forearm exercise.

Authors:  O J Hartling; T L Svendsen; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Diazoxide treatment for insulinoma: a national UK survey.

Authors:  G V Gill; O Rauf; I A MacFarlane
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

5.  Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models.

Authors:  Yanxiu Guo; Haoxia Zeng; Xiaohong Chang; Chaohua Wang; Heng Cui
Journal:  BMC Cancer       Date:  2018-01-16       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.